Catheter ablation of short-coupled variant of torsade de pointes.
3D-mapping
Moderator band
Purkinje
Short-coupled variant of torsade de pointes
Journal
Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
15
11
2020
accepted:
07
03
2021
pubmed:
27
3
2021
medline:
4
5
2022
entrez:
26
3
2021
Statut:
ppublish
Résumé
The short-coupled variant of torsade de pointes (sc-TdP) is a malignant arrhythmia that frequently presents with ventricular fibrillation (VF) electrical storm. Verapamil is considered the first-line therapy of sc-TdP while catheter ablation is not widely adopted. The aim of this study was to determine the origin of sc-TdP and to assess the outcome of catheter ablation using 3D-mapping. We retrospectively analyzed five patients with sc-TdP who underwent 3D-mapping and ablation of sc-TdP at five different institutions. Four patients initially presented with sudden cardiac arrest, one patient experienced recurrent syncope as the first manifestation. All patients demonstrated a monomorphic premature ventricular contraction (PVC) with late transition left bundle branch block pattern, superior axis, and a coupling interval of less than 300 ms. triggering recurrent TdP and VF. In four patients, the culprit PVC was mapped to the free wall insertion of the moderator band (MB) with a preceding Purkinje potential in two patients. Catheter ablation using 3D-mapping and intracardiac echocardiography eliminated sc-TdP in all patients, with no recurrence at mean 2.7 years (range 6 months to 8 years) of follow-up. 3D-mapping and intracardiac echocardiography demonstrate that sc-TdP predominantly originates from the MB free wall insertion and its Purkinje network. Catheter ablation of the culprit PVC at the MB free wall junction leads to excellent short- and long-term results and should be considered as first-line therapy in recurrent sc-TdP or electrical storm.
Sections du résumé
BACKGROUND
BACKGROUND
The short-coupled variant of torsade de pointes (sc-TdP) is a malignant arrhythmia that frequently presents with ventricular fibrillation (VF) electrical storm. Verapamil is considered the first-line therapy of sc-TdP while catheter ablation is not widely adopted. The aim of this study was to determine the origin of sc-TdP and to assess the outcome of catheter ablation using 3D-mapping.
METHODS AND RESULTS
RESULTS
We retrospectively analyzed five patients with sc-TdP who underwent 3D-mapping and ablation of sc-TdP at five different institutions. Four patients initially presented with sudden cardiac arrest, one patient experienced recurrent syncope as the first manifestation. All patients demonstrated a monomorphic premature ventricular contraction (PVC) with late transition left bundle branch block pattern, superior axis, and a coupling interval of less than 300 ms. triggering recurrent TdP and VF. In four patients, the culprit PVC was mapped to the free wall insertion of the moderator band (MB) with a preceding Purkinje potential in two patients. Catheter ablation using 3D-mapping and intracardiac echocardiography eliminated sc-TdP in all patients, with no recurrence at mean 2.7 years (range 6 months to 8 years) of follow-up.
CONCLUSION
CONCLUSIONS
3D-mapping and intracardiac echocardiography demonstrate that sc-TdP predominantly originates from the MB free wall insertion and its Purkinje network. Catheter ablation of the culprit PVC at the MB free wall junction leads to excellent short- and long-term results and should be considered as first-line therapy in recurrent sc-TdP or electrical storm.
Identifiants
pubmed: 33770204
doi: 10.1007/s00392-021-01840-z
pii: 10.1007/s00392-021-01840-z
pmc: PMC9054881
doi:
Substances chimiques
DNA-Binding Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
502-510Informations de copyright
© 2021. The Author(s).
Références
Front Cardiovasc Med. 2018 Sep 18;5:123
pubmed: 30280100
J Arrhythm. 2020 Mar 09;36(2):215-270
pubmed: 32256872
Heart Rhythm O2. 2020 Aug 26;1(5):394-398
pubmed: 34113896
Circ Res. 2013 May 10;112(10):1310-22
pubmed: 23532596
Arq Bras Cardiol. 2014 Jun;102(6):e60-4
pubmed: 25004426
Heart Rhythm. 2019 Jul;16(7):1121-1126
pubmed: 30716412
JACC Clin Electrophysiol. 2017 Mar;3(3):313-314
pubmed: 29759527
Circulation. 1994 Jan;89(1):206-15
pubmed: 8281648
Nat Med. 1996 Dec;2(12):1393-5
pubmed: 8946843
Circ Arrhythm Electrophysiol. 2018 Aug;11(8):e005913
pubmed: 30354313
Circulation. 2018 May 22;137(21):2278-2294
pubmed: 29784681
J Am Coll Cardiol. 2009 Aug 4;54(6):522-8
pubmed: 19643313
Nat Rev Cardiol. 2016 Mar;13(3):155-66
pubmed: 26727298
Indian Pacing Electrophysiol J. 2005 Jan 01;5(1):25-34
pubmed: 16943940
Heart Rhythm. 2017 Jan;14(1):98-107
pubmed: 27756708
Circulation. 2002 Aug 20;106(8):962-7
pubmed: 12186801
Heart Rhythm. 2019 May;16(5):781-790
pubmed: 30391571
Hellenic J Cardiol. 2008 Sep-Oct;49(5):360-4
pubmed: 18846928
Pacing Clin Electrophysiol. 2013 Mar;36(3):e77-9
pubmed: 21039642
Circ Arrhythm Electrophysiol. 2017 Aug;10(8):
pubmed: 28794084
Int J Cardiol. 2015 Feb 1;180:228-36
pubmed: 25463374
J Electrocardiol. 2001 Jul;34(3):271-5
pubmed: 11455519
J Cardiovasc Electrophysiol. 2013 Jan;24(1):97-100
pubmed: 22882745
J Cardiovasc Electrophysiol. 2003 Mar;14(3):329
pubmed: 12716122
Neth Heart J. 2008 Aug;16(7-8):246-9
pubmed: 18711611
HeartRhythm Case Rep. 2019 Sep 10;5(12):578-581
pubmed: 31890580
Heart Rhythm. 2015 Jan;12(1):67-75
pubmed: 25240695